A committee of experts voted in favor of a new shot administered to pregnant women, one in a series of new ways to arm the very young against a life-threatening virus.
Lawmakers and Sam Altman, the chief executive of OpenAI, agreed that artificial intelligence should be regulated. How to do that remains an open question.
The program, which will include a partnership with pharmacy chains, will cover the administrative costs of giving doses to patients when the shots move to the commercial market later this year.